Healthcare Services vs Pennant
HCSG and PNTG side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HCSG and PNTG compare
Healthcare Services is the larger company, worth 1.3 times as much as Pennant ($1.7B against $1.3B).
On earnings, Healthcare Services is cheaper: it trades at 16.7× trailing earnings, against 41.1× for Pennant.
Pennant grew revenue faster over the last twelve months (37.9% versus 4.0% for Healthcare Services).
Healthcare Services keeps more of each dollar of sales as profit, with a net margin of 5.6% compared with 2.9% at Pennant.
Healthcare Services scores higher on the StockData Score (18 against 13 for Pennant), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HCSG | PNTG |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $1.3B |
| Share price | $24.86 | $37.03 |
| Change, 1 year | 43.4% | 48.8% |
| Change, 5 years | 39.9% | 81.1% |
| Beta (5Y) | 0.27 | 0.62 |
| Employees | 36K | 9,700 |
| StockData Score | ||
| Total score | 18 (better) | 13 |
| Valuation score | 5 (better) | 3 |
| Growth score | 4 | 4 |
| Performance score | 3 | 3 |
| Health score | 6 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 16.7× (better) | 41.1× |
| P/S | 0.9× (better) | 1.2× |
| P/B | 3.2× | – |
| EV/EBITDA | 10.5× (better) | 18.4× |
| P/FCF | 15.7× (better) | 37.3× |
| PEG | 0.80 | 0.73 (better) |
| FCF yield | 6.4% (better) | 2.7% |
| Fair value | $30.37 | $29.86 |
| Margin of safety | 18.1% (better) | −24.0% |
| Growth | ||
| Revenue growth (TTM) | 4.0% | 37.9% (better) |
| Revenue growth, 5Y average | 0.86% | 19.4% (better) |
| Net income growth (TTM) | 164% (better) | 20.5% |
| EPS growth (TTM) | 176% (better) | 15.4% |
| EPS growth, 5Y average | −9.3% | 10.1% (better) |
| Profitability | ||
| Gross margin | 16.1% | 18.5% (better) |
| Operating margin | – | 5.6% |
| Net margin | 5.6% (better) | 2.9% |
| FCF margin | 5.7% (better) | 3.1% |
| Return on equity | 20.4% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Net debt / EBITDA | – | −0.14 |
| Interest coverage | – | 5.8× |
| Current ratio | 2.82 (better) | 1.20 |
| Altman Z-score | 6.48 (better) | 2.66 |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 4.5% | – |
| Shareholder yield | 4.5% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 108% | 92.7% |
| Held by insiders | 1.3% | 5.0% |
| Insider net buying, 12 months | −$3.8M | −$690K (better) |
| Short interest, % of float | 3.7% | 3.5% |
Go deeper
- HCSG stock overview
- HCSG income statement
- HCSG valuation and score
- PNTG stock overview
- PNTG income statement
- PNTG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.